Esios, Shaila Faith .
HRN: 10-33-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2025
CEFUROXIME 750MG (VIAL)
07/15/2025
07/22/2025
IV
750 Mg
Ptor Then Q8
Clavicular Fracture
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes